Who to call at Samsung Biologics, and when

Fundz watches for the moments Samsung Biologics starts buying, and tells you who to reach.

An alert the day Samsung Biologics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Samsung Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Samsung Biologics. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Samsung Biologics Secures a 434.3 Billion Won Contract

Nov 03, 2026

Contract Type

contract

South KoreaManufacturingBiotechnology

Description

Samsung Biologics has secured a significant contract worth 434.3 billion won. This contract is expected to enhance the company's capabilities in biopharmaceutical manufacturing and development. The agreement highlights Samsung Biologics' position as a key player in the industry.

Company Information

Company

Samsung Biologics

Location

South Korea

About

Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) that offers comprehensive services from cell line development to final aseptic fill/finish. The company operates state-of-the-art, CGMP compliant facilities and has increased its biomanufacturing capacity to meet growing demand. With a commitment to innovative technologies and customized solutions, Samsung Biologics supports its clients' evolving needs in the biopharmaceutical sector. The company also has a presence in the U.S. and Europe to better collaborate with international clients.